Wholesale of pharmaceutical and medical goods
LIVANOVA NORWAY AS
Revenue 2024
NOK 36.4m
Operating profit
NOK 6.2m
Equity
NOK 20.9m
Incorporated
2007
Share capital
NOK 300,000
Key figures · 2024
Current ratio
4.50
Equity ratio
77.8%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 17.1% | |
| Net margin (%%) | 14.7% | |
| Return on assets (%%) | 23.2% | |
| Likviditet | ||
| Current ratio | 4.50 | |
| Working capital | 20.8m | |
| Soliditet | ||
| Equity ratio (%%) | 77.8% | |
| Debt-to-equity ratio | 0.29 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.